10x Capital Venture Acquisition Iii's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for 10x Capital Venture Acquisition Iii in the third quarter 2023?
Due to the lack of equity, it was not possible to calculate 10x Capital Venture Acquisition Corp Iii's return on equity (ROE) in its third quarter 2023

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-1	2	4	1	1
Return On Equity (TTM)	-	-	-	-	-
VCXBU's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-19	-16	-14	-17	-14
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	5895.76 %	-95.84 %	-

Back to VCXBU Management Effectiveness >> VCXBU's 5 Years Annual ROE >> Compare VCXBU ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

VCXBU Annual Return On Equity	(Dec 31 2022) 2022
Total Equity in Millions	-17	0	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	1	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

Back to VCXBU Management Effectiveness >> VCXBU's 5 Years Annual ROE >> Compare VCXBU ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
VCXBU's' Return on Equity at Yahoo Finance
VCXBU's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for VCXBU's Competitors
Subscribers only: Roe for 10x Capital Venture Acquisition Iii's Suppliers
Subscribers only: Return On Equity for VCXBU's Customers

Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector	ROE
West Pharmaceutical Services Inc	20.20 %
Cadre Holdings inc	20.20 %
Tenax Therapeutics Inc	19.94 %
Kewaunee Scientific Corporation	19.54 %
Lantheus Holdings Inc	19.42 %
Iqvia Holdings Inc	19.20 %
Select Medical Holdings Corp	19.01 %
Corcept Therapeutics Inc	18.99 %
Alkermes Plc	18.33 %
Ensign Group Inc	18.32 %
Catalyst Pharmaceuticals Inc	18.27 %
Option Care Health Inc	18.22 %
Patterson Companies Inc	18.20 %
Dexcom Inc	17.27 %
United Therapeutics Corporation	17.10 %
Regeneron Pharmaceuticals Inc	16.79 %
Ufp Technologies Inc	16.44 %
Tactile Systems Technology Inc	16.11 %
Haemonetics Corporation	15.43 %
Eton Pharmaceuticals Inc	15.41 %
Charles River Laboratories International inc	15.18 %
Stryker Corp	15.03 %
Alpha Pro Tech Ltd	14.19 %
Utah Medical Products Inc	14.15 %
Abbott Laboratories	13.84 %
Quest Diagnostics Inc	13.23 %
Intuitive Surgical Inc	13.14 %
Bio techne Corp	13.06 %
Puma Biotechnology Inc	12.75 %
Orasure Technologies Inc	12.63 %

Date modified: 2026-06-22T16:30:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.